ViiV Healthcare’s global community outreach gives hope to thousands of people in Africa and other regions of the developing world. These programs include research and development of new HIV medicines, preferential pricing of medicine, community investments, and innovative partnerships.
Research & development of antiretrovirals
- Undertaking R&D for the prevention and treatment of HIV/AIDS
- Have supported more than 25 ongoing and past clinical trials in developing countries, including 19 in Africa
Community investment
- Positive Action, ViiV Healthcare program of HIV education, care, and community support has been ongoing since 1992
- GlaxoSmithKline’s France Foundation has supported 31 programs in 12 African countries focusing on HIV prevention, education training, and healthcare in developing countries
- Community-led initiatives in more than 100 countries around the world
Innovative partnerships
- ViiV Healthcare has extended voluntary licenses to several companies to produce antiretrovirals for sale and use in developing countries
Next >> Positive action
